A validated biomarker panel to identify peripheral artery disease

Vascular Medicine (United Kingdom)

Volumn 17, Issue 6, 2012, Pages 386-393

  Hiatt, William R ^a,b   Zakharyan, Armen ^b   Fung, Eric T ^c   Crutcher, Gillian ^c   Smith, Alan ^d   Stanford, Chriss ^b   Cooke, John ^e  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CPC Clinical Research   (United States)

^c Vermillion Inc   (United States)

^d Applied Clinical Intelligence   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

atherosclerosis; biological markers; clinical trials; peripheral artery disease; peripheral vascular diseases

Indexed keywords

BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYSTATIN C; GLUCOSE;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; DIABETES MELLITUS; FALSE POSITIVE RESULT; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTION; PREDICTIVE VALUE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SMOKING;

AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CYSTATIN C; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84870156931     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X12463491     Document Type: Article

References (28)

1. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006 ; 295: 180-189 (Pubitemid 43076437)
2. Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007 ; 297: 1197-1206 (Pubitemid 46465728)
3. Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A meta-analysis. JAMA. 2008 ; 300: 197-208 (Pubitemid 351969304)
4. McDermott MM, Mehta S, Liu K, et al. Leg symptoms, the ankle-brachial index, and walking ability in patients with peripheral arterial disease. J Gen Intern Med. 1999 ; 14: 173-181 (Pubitemid 29161775)
5. McDermott MM, Greenland P, Liu K, et al. The ankle brachial index is associated with leg function and physical activity: The Walking and Leg Circulation Study. Ann Intern Med. 2002 ; 136: 873-883 (Pubitemid 34625699)
6. Hiatt WR, Marshall JA, Baxter J, et al. Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. J Clin Epidemiol. 1990 ; 43: 597-606 (Pubitemid 20178549)
7. Criqui MH, Fronek A, Klauber MR, Barrett-Connor E, Gabriel S. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: Results from noninvasive testing in a defined population. Circulation. 1985 ; 71: 516-522 (Pubitemid 15133810)
8. McDermott MM, Liu K, Greenland P, et al. Functional decline in peripheral arterial disease: Associations with the ankle brachial index and leg symptoms. JAMA. 2004 ; 292: 453-461 (Pubitemid 38988954)
9. McDermott MM, Criqui MH, Greenland P, et al. Leg strength in peripheral arterial disease: Associations with disease severity and lower-extremity performance. J Vasc Surg. 2004 ; 39: 523-530 (Pubitemid 38298621)
10. McDermott MM, Ferrucci L, Guralnik JM, et al. The ankle-brachial index is associated with the magnitude of impaired walking endurance among men and women with peripheral arterial disease. Vasc Med. 2010 ; 15: 251-257
11. Rooke TW, Hirsch AT, Misra S, et al. 2011 ACC/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 ; 124: 2020-2045
12. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001 ; 286: 1317-1324 (Pubitemid 33015522)
13. Mohler ER, Treat-Jacobson D, Reilly MP, et al. Utility and barriers to performance of the ankle-brachial index in primary care practice. Vasc Med. 2004 ; 9: 253-260 (Pubitemid 40202240)
14. Wilson AM, Kimura E, Harada RK, et al. Beta2-microglobulin as a biomarker in peripheral arterial disease: Proteomic profiling and clinical studies. Circulation. 2007 ; 116: 1396-1403 (Pubitemid 47417566)
15. Arpegård J, Ostergren J, de Faire U, Hansson LO, Svensson P.. Cystatin C-A marker of peripheral atherosclerotic disease?. Atherosclerosis. 2008 ; 199: 397-401
16. Beckman JA, Preis O, Ridker PM, Gerhard-Herman M. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Am J Cardiol. 2005 ; 96: 1374-1378 (Pubitemid 41566616)
17. Criqui MH, Ho LA, Denenberg JO, Ridker PM, Wassel CL, McDermott MM. Biomarkers in peripheral arterial disease patients and near- and longer-term mortality. J Vasc Surg. 2010 ; 52: 85-90
18. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001 ; 285: 2481-2485 (Pubitemid 32433842)
19. Fung ET, Wilson AM, Zhang F, et al. A biomarker panel for peripheral arterial disease. Vasc Med. 2008 ; 13: 217-224
20. Lloyd-Jones DM. Cardiovascular risk prediction: Basic concepts, current status, and future directions. Circulation. 2010 ; 121: 1768-1777
21. Dhangana R, Murphy TP, Coll JR, et al. Prevalence of abnormal ankle-brachial index among individuals with low or intermediate Framingham risk scores. J Vasc Interv Radiol. 2011 ; 22: 1077-1082
22. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation. 1995 ; 91: 1472-1479
23. Zheng ZJ, Sharrett AR, Chambless LE, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 1997 ; 131: 115-125 (Pubitemid 27240104)
24. Berger JS, Eraso LH, Xie D, Sha D, Mohler ER. Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1999-2004. Atherosclerosis. 2010 ; 213: 586-591
25. Pande RL, Perlstein TS, Beckman JA, Creager MA. Secondary Prevention and Mortality in Peripheral Artery Disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation. 2011 ; 124: 17-23
26. Collins TC, Petersen NJ, Suarez-Almazor M, Ashton CM. The prevalence of peripheral arterial disease in a racially diverse population. Arch Intern Med. 2003 ; 163: 1469-1474 (Pubitemid 36758920)
27. Makowsky MJ, McAlister FA, Galbraith PD, et al. Lower extremity peripheral arterial disease in individuals with coronary artery disease: Prognostic importance, care gaps, and impact of therapy. Am Heart J. 2008 ; 155: 348-355
28. Shinkai S, Chaves PH, Fujiwara Y, et al. Beta2-microglobulin for risk stratification of total mortality in the elderly population: Comparison with cystatin C and C-reactive protein. Arch Intern Med. 2008 ; 168: 200-206 (Pubitemid 351185888)